Patent · US Active

Methods and compositions for treating diabetes, metabolic syndrome and other conditions

US10517868B2 · kind B2 · utility

6Cited by

3References

2Claims

0Family size

Assignee

STRONGBRIDGE DUBLIN LIMITED · IE

Inventor

Per Marin · Mölndal, SE

Key dates

Filing date	Oct 4, 2018
Grant date	Dec 31, 2019
Priority date	—
Expiry date	Oct 4, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Pharmaceuticals compositions comprising the 2S, 4R, ketoconazole enantiomer or its pharmaceutically acceptable salts, hydrates, and solvates, that are substantially free of the 2R, 4S ketoconazole enantiomer are useful to reduce cortisol synthese and for the treatment of type 2 diabetes, hyperglycemia, obesity, insulin resistance, dyslipidemia, hyperlipidemia, hypertension, Metabolic Syndrome, and other diseases and conditions, including but not limited to Cushing's Syndrome, depression, and glaucoma.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.